Tracon Pharmaceuticals, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Tracon Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2014 to Q2 2024.
  • Tracon Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $73K.
  • Tracon Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $12.5M.
  • Tracon Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $5.69M.
  • Tracon Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.24M, a 288% decline from 2021.
  • Tracon Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$320K, a 42% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $12.5M $73K +$5.58M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $6.92M $44K +$1.24M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $5.69M $32K +$1.2M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $4.49M $12.4M +$12.4M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$7.92M -$5.51M -$5.52M -61289% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$2.41M -$1.19M -$1.16M -4311% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$1.24M -$1.17M -$1.12M -2278% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$125K -$58K +$13K +18.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$138K $9K +$100K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$238K -$27K +$82K +75.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$320K -$49K +$85K +63.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 -$405K -$71K +$73K +50.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$478K -$91K +$46K +33.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$524K -$109K +$28K +20.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$552K -$134K -$10K -8.07% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-08
Q3 2020 -$542K -$144K -$26K -22% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$516K -$137K -$51K -59.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$465K -$137K -$87K -174% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$378K -$124K -$99K -396% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-15
Q3 2019 -$279K -$118K -$116K -5800% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$163K -$86K -$69K -406% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$94K -$50K +$125K +71.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$219K -$25K +$181K +87.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$400K -$2K +$222K +99.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$622K -$17K +$219K +92.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$841K -$175K +$52K +22.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$893K -$206K +$33K +13.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 -$926K -$224K +$50K +18.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$976K -$236K +$51K +17.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$1.03M -$227K +$5K +2.16% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$1.03M -$239K -$28K -13.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$1M -$274K -$62K -29.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$942K -$287K -$50K -21.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$892K -$232K +$51K +18% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$943K -$211K +$85K +28.7% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 -$1.03M -$212K +$4K +1.85% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$1.03M -$237K -$148K -166% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$884K -$283K -$254K -876% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$630K -$296K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 -$216K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$89K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$29K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.